Company / Working Capital
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$302.2M
FY2025
5-year range
$302.2M / $1.0B
FY2021-FY2025
Trend
-29.6%
vs FY2024
Sector context
#91 of 160
Health Care
What the data says
At $302M, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s working capital ranks #91 of 160 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from $32M in FY2019 to $1.0B in FY2021.
Based on SEC 10-K filings.
$302M in FY2025 with a 5-year CAGR of -1.0%.
Declined from $647M to $302M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -19.9%
- 5-Year CAGR
- -1.0%
- 10-Year CAGR
- -
Sector benchmark
#91 of 160 in Health CareTop 57% of 160This company $302.2M Sector average $757.1M
▼
-60.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -1.0%, indicating a declining trend.
- In FY2025, working capital decreased 29.6% year-over-year.
- Ranks #91 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $302.2M | -29.6% |
| FY2024 | $429.4M | -33.6% |
| FY2023 | $647.0M | +9.9% |
| FY2022 | $588.7M | -42.8% |
| FY2021 | $1.0B | +224.7% |
| FY2020 | $317.1M | +894.2% |
| FY2019 | $31.9M | -69.6% |
| FY2018 | $104.8M | +43.6% |
| FY2017 | $73.0M | -3.0% |
| FY2016 | $75.2M | +4.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026